
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.240 | 0.340 | 0.100 |
Shares | 98.640 | 98.640 | 0.000 |
Convertible | 0.480 | 0.480 | 0.000 |
Preferred | 0.010 | 0.010 | 0.000 |
Other | 0.630 | 0.630 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.823 | 17.767 |
Price to Book | 3.424 | 3.804 |
Price to Sales | 4.970 | 5.020 |
Price to Cash Flow | 26.290 | 15.605 |
Dividend Yield | 0.370 | 0.540 |
5 Years Earnings Growth | 17.646 | 13.106 |
Number of long holdings: 81
Number of short holdings: 11
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 8.76 | 445.43 | +0.76% | |
Amgen | US0311621009 | 5.09 | 288.47 | +0.10% | |
Ascendis Pharma AS | US04351P1012 | 4.61 | 175.69 | +7.89% | |
Soleno Therapeutics | US8342033094 | 4.46 | 75.6600 | +3.15% | |
argenx ADR | US04016X1019 | 4.17 | 584.61 | +1.98% | |
Verona Pharma ADR | US9250501064 | 4.03 | 84.100 | +3.57% | |
Avidity Bio | US05370A1088 | 3.92 | 33.17 | +7.07% | |
Madrigal Pharma | US5588681057 | 3.45 | 272.67 | -0.94% | |
Revolution Med | US76155X1000 | 3.34 | 40.65 | +3.17% | |
Akero Therapeutics | US00973Y1082 | 3.15 | 50.73 | +2.18% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S Horizon Global Technology FundA1u | 611.46M | -10.68 | 13.48 | 14.47 | ||
S Horizon Global Technology Fund Au | 2.35B | -10.68 | 13.48 | 14.48 | ||
S Horizon Global Technology Fund G2 | 325.17M | -10.35 | 14.71 | 15.67 | ||
S Horizon Global Technology Fund Xu | 29.85M | -10.86 | 12.80 | 13.79 | ||
Henderson Horizon Global Technology | 57.92M | -10.44 | 14.39 | 15.33 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review